Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Number of holders
-
139
-
Total 13F shares, excl. options
-
57,920,959
-
Shares change
-
-8,035,569
-
Total reported value, excl. options
-
$801,022,755
-
Value change
-
-$114,549,555
-
Put/Call ratio
-
117%
-
Number of buys
-
67
-
Number of sells
-
-62
-
Price
-
$13.83
Significant Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q4 2020
176 filings reported holding AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value as of Q4 2020.
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57,920,959 shares
of 130,702,820 outstanding shares and own 44% of the company stock.
Largest 10 shareholders include HealthCor Management, L.P. (6,937,448 shares), FMR LLC (5,762,773 shares), NEA Management Company, LLC (5,172,683 shares), ORBIMED ADVISORS LLC (4,754,000 shares), PICTET ASSET MANAGEMENT LTD (3,625,994 shares), Point72 Asset Management, L.P. (2,139,461 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (2,086,397 shares), Avidity Partners Management LP (2,000,000 shares), Connor, Clark & Lunn Investment Management Ltd. (1,999,972 shares), and KINGDON CAPITAL MANAGEMENT, L.L.C. (1,668,208 shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.